John Canan
Vermogen: 4 M $ op 31-05-2026
Vermogen: 4 M $ op 31-05-2026
John Canan worked for Merck & Co., Inc. as Senior VP-Finance & Global Controller from 2014 to 2014.
He also worked for Schering-Plough Corp.
as Chief Accounting Officer, SVP & Global Controller from 2009 to 2009, and for Merck Sharp & Dohme Corp.
as Senior Vice President & Controller from 2009 to 2009.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Terex Corp.
Terex Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets aerial work platforms and materials processing machinery 0,06% | 27-04-2026 | 64.456 ( 0,06% ) | 4 M $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Comptroller/Controller/Auditor | 01-03-2014 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Comptroller/Controller/Auditor | 03-11-2009 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Auditor | 01-11-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau